Orion Oyj
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORINY research report →
About the company
Orion Oyj is a Finnish pharmaceutical company specializing in the creation, production, and commercialization of medicines for both human and animal health, as well as the active components (APIs) essential for drug formulation. Its operations extend across Finland, the Nordic region, wider Europe, North America, and various international markets. The company's diverse product portfolio encompasses both prescribed medications and over-the-counter (OTC) healthcare solutions.
- CEO
- Liisa Hurme
- IPO
- 2014
- Employees
- 3,943
- HQ
- Espoo, FI
Price Chart
- Market Cap
- $21.87B
- P/E
- 19.15
- P/S
- 5.19
- P/B
- 9.03
- EV/EBITDA
- 14.72
- Div Yield
- 2.39%
- Gross Margin
- 64.79%
- Op Margin
- 34.11%
- Net Margin
- 27.12%
- ROE
- 48.73%
- ROIC
- 35.37%
- Revenue
- $1.89B · 22.50%
- Net Income
- $480.55M · 45.67%
- EPS
- $0.86 · -27.23%
- Op Income
- $631.60M
- FCF YoY
- 6.15%
- 52W High
- $42.75
- 52W Low
- $30.89
- 50D MA
- $38.27
- 200D MA
- $37.80
- Beta
- 0.29
- Avg Volume
- 150
Get TickerSpark's AI analysis on ORINY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ORINY coverage
Recent articles, reports, and earnings notes.
No research on ORINY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ORINY report →Similar companies
Peers in the same neighborhood.